These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 8225498)

  • 21. Neuroscience and accelerator mass spectrometry.
    Palmblad M; Buchholz BA; Hillegonds DJ; Vogel JS
    J Mass Spectrom; 2005 Feb; 40(2):154-9. PubMed ID: 15706618
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adduction of biomacromolecules with acrylamide (AA) in mice at environmental dose levels studied by accelerator mass spectrometry.
    Xie Q; Sun H; Liu Y; Ding X; Fu D; Liu K
    Toxicol Lett; 2006 May; 163(2):101-8. PubMed ID: 16280212
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of nitrobenzene-induced DNA and hemoglobin adductions by dietary constituents.
    Li H; Cheng Y; Wang H; Sun H; Liu Y; Liu K; Peng S
    Appl Radiat Isot; 2003 Mar; 58(3):291-8. PubMed ID: 12595006
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Accelerator mass spectrometry of small biological samples.
    Salehpour M; Forsgard N; Possnert G
    Rapid Commun Mass Spectrom; 2008 Dec; 22(23):3928-34. PubMed ID: 18980253
    [TBL] [Abstract][Full Text] [Related]  

  • 25. DNA and protein adduct formation in the colon and blood of humans after exposure to a dietary-relevant dose of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine.
    Dingley KH; Curtis KD; Nowell S; Felton JS; Lang NP; Turteltaub KW
    Cancer Epidemiol Biomarkers Prev; 1999 Jun; 8(6):507-12. PubMed ID: 10385140
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Application of accelerated mass spectrometry (AMS) in DNA adduct quantification and identification.
    Turteltaub KW; Dingley KH
    Toxicol Lett; 1998 Dec; 102-103():435-9. PubMed ID: 10022292
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Accelerator mass spectrometry for quantitative in vivo tracing.
    Vogel JS
    Biotechniques; 2005 Jun; Suppl():25-9. PubMed ID: 16528913
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A novel 14C-postlabeling assay using accelerator mass spectrometry for the detection of O6-methyldeoxy-guanosine adducts.
    Tompkins EM; Farmer PB; Lamb JH; Jukes R; Dingley K; Ubick E; Turteltaub KW; Martin EA; Brown K
    Rapid Commun Mass Spectrom; 2006; 20(5):883-91. PubMed ID: 16470516
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Application of accelerator mass spectrometry (AMS) for high-sensitivity measurements of 14CO2 in long-term studies of fat metabolism.
    Stenström K; Leide-Svegborn S; Erlandsson B; Hellborg R; Mattsson S; Nilsson LE; Nosslin B; Skog G; Wiebert A
    Appl Radiat Isot; 1996 Apr; 47(4):417-22. PubMed ID: 8624508
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Current perspectives of 14C-isotope measurement in biomedical accelerator mass spectrometry.
    Lappin G; Garner RC
    Anal Bioanal Chem; 2004 Jan; 378(2):356-64. PubMed ID: 14624324
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The impact of glucuronidation on the bioactivation and DNA adduction of the cooked-food carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine in vivo.
    Malfatti MA; Ubick EA; Felton JS
    Carcinogenesis; 2005 Nov; 26(11):2019-28. PubMed ID: 15944213
    [TBL] [Abstract][Full Text] [Related]  

  • 32. DNA isolation and sample preparation for quantification of adduct levels by accelerator mass spectrometry.
    Dingley KH; Ubick EA; Vogel JS; Ognibene TJ; Malfatti MA; Kulp K; Haack KW
    Methods Mol Biol; 2014; 1105():147-57. PubMed ID: 24623226
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lactoperoxidase-catalyzed activation of carcinogenic aromatic and heterocyclic amines.
    Gorlewska-Roberts KM; Teitel CH; Lay JO; Roberts DW; Kadlubar FF
    Chem Res Toxicol; 2004 Dec; 17(12):1659-66. PubMed ID: 15606142
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of accelerator mass spectrometry for studies in nutrition.
    Jackson GS; Weaver C; Elmore D
    Nutr Res Rev; 2001 Dec; 14(2):317-34. PubMed ID: 19087429
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Food-derived mutagens and carcinogens.
    Wakabayashi K; Nagao M; Esumi H; Sugimura T
    Cancer Res; 1992 Apr; 52(7 Suppl):2092s-2098s. PubMed ID: 1544146
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel use of accelerator mass spectrometry for the quantification of low levels of systemic therapeutic recombinant protein.
    Lappin G; Garner RC; Meyers T; Powell J; Varley P
    J Pharm Biomed Anal; 2006 Jun; 41(4):1299-302. PubMed ID: 16554138
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biological and biomedical (14)C-accelerator mass spectrometry and graphitization of carbonaceous samples.
    Chung IM; Kim SH
    Analyst; 2013 Jun; 138(12):3347-55. PubMed ID: 23626987
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk assessment of DNA-reactive carcinogens in food.
    Jeffrey AM; Williams GM
    Toxicol Appl Pharmacol; 2005 Sep; 207(2 Suppl):628-35. PubMed ID: 15990138
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Separation of 32P-labelled nucleoside 3',5'-bisphosphate adducts by HPLC.
    Pfau W; Lecoq S; Hughes NC; Seidel A; Platt KL; Grover PL; Phillips DH
    IARC Sci Publ; 1993; (124):233-42. PubMed ID: 8225490
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analytical performance of accelerator mass spectrometry and liquid scintillation counting for detection of 14C-labeled atrazine metabolites in human urine.
    Gilman SD; Gee SJ; Hammock BD; Vogel JS; Haack K; Buchholz BA; Freeman SP; Wester RC; Hui X; Maibach HI
    Anal Chem; 1998 Aug; 70(16):3463-9. PubMed ID: 9726169
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.